Abstract
Heart disease is the leading cause of mortality in the USA and accounts for 17% of healthcare expenses, with projected costs of cardiovascular disease expected to triple in the next two decades. Psychiatric conditions such as depression, anxiety, and delirium, among others, are common in patients with cardiovascular disease, and their presence has been linked to worse medical outcomes and higher healthcare costs. In this book chapter, we will discuss the effects of different psychiatric conditions in patients undergoing coronary artery bypass grafting, cardiac valvular surgery, left ventricular assist device implantation, and in patients with automatic implantable cardiac defibrillators.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States. Circulation. 2011;123:933–44.
Caro MA, Rosenthal JL, Kendall K, Pozuelo L, Funk MC. What the psychiatrist needs to know about ventricular assist devices: a comprehensive review. Psychosomatics. 2016;57:229–37.
Goyal TM, Idler EL, Krause TJ, Contrada RJ. Quality of life following cardiac surgery: impact of the severity and course of depressive symptoms. Psychosom Med. 2005;67:759–65.
Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL, Huffman JC, Celano CM, Beach SR, Motiwala SR, Januzzi JL. Depression and cardiac disease: epidemiology, mechanisms, and diagnosis. Cardiovasc Psychiatry Neurol. 2013;2013:e695925.
Rutledge T, Reis VA, Linke SE, Greenberg BH, Mills PJ. Depression in heart failure: a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol. 2006;48:1527–37.
Kazmierski J, Kowman M, Banach M, Pawelczyk T, Okonski P, Iwaszkiewicz A, Zaslonka J, Sobow T, Kloszewska I. Preoperative predictors of delirium after cardiac surgery: a preliminary study. Gen Hosp Psychiatry. 2006;28:536–8.
Tully PJ, Baker RA. Depression, anxiety, and cardiac morbidity outcomes after coronary artery bypass surgery: a contemporary and practical review. J Geriatr Cardiol. 2012;9:197–208.
Milbrandt EB, Deppen S, Harrison PL, Shintani AK, Speroff T, Stiles RA, Truman B, Bernard GR, Dittus RS, Ely EW. Costs associated with delirium in mechanically ventilated patients. Crit Care Med. 2004;32:955–62.
Sato K, Kubota K, Oda H, Taniguchi T. The impact of delirium on outcomes in acute, non-intubated cardiac patients. Eur Heart J Acute Cardiovasc Care. 2015. https://doi.org/10.1177/2048872615624239.
Cogswell R, Smith E, Hamel A, et al. Substance abuse at the time of left ventricular assist device implantation is associated with increased mortality. J Heart Lung Transplant. 2014;33:1048–55.
Leto L, Feola M. Cognitive impairment in heart failure patients. J Geriatr Cardiol. 2014;11:316–28.
Benjamin EJ, Blaha MJ, Chiuve SE, et al. Heart disease and stroke statistics—2017 update: a report from the American Heart Association Circulation CIR0000000000000485; 2017.
Adult cardiac surgery database: executive summary: 10 years: STS period ending 6/30/2015. Society of Thoracic Surgeons web site. http://www.sts.org/sites/default/files/documents/2015Harvest3_ ExecutiveSummary.pdf.
Diagnostic criteria and codes. Diagn Stat Man Ment Disord. 2013. https://doi.org/10.5555/appi.books.9780890425596.Section2.
Sockalingam S, Parekh N, Israel Bogoch I, et al. Delirium in the postoperative cardiac patient: a review. J Card Surg. 2005;20:560–7.
Gottesman RF, Grega MA, Bailey MM, Pham LD, Zeger SL, Baumgartner WA, Selnes OA, McKhann GM. Delirium after coronary artery bypass graft surgery and late mortality. Ann Neurol. 2010;67:338–44.
Koster S, Hensens AG, Schuurmans MJ, van der Palen J. Consequences of delirium after cardiac operations. Ann Thorac Surg. 2012;93:705–11.
Saczynski JS, Marcantonio ER, Quach L, Fong TG, Gross A, Inouye SK, Jones RN. Cognitive trajectories after postoperative delirium. N Engl J Med. 2012;367:30–9.
Martin B-J, Buth KJ, Arora RC, Baskett RJF. Delirium: a cause for concern beyond the immediate postoperative period. Ann Thorac Surg. 2012;93:1114–20.
Rudolph JL, Inouye SK, Jones RN, Yang FM, Fong TG, Levkoff SE, Marcantonio ER. Delirium: an independent predictor of functional decline after cardiac surgery. J Am Geriatr Soc. 2010;58:643–9.
Brown CH. Delirium in the cardiac surgical intensive care unit. Curr Opin Anaesthesiol. 2014;27:117–22.
Groen JA, Banayan D, Gupta S, Xu S, Bhalerao S. Treatment of delirium following cardiac surgery. J Card Surg. 2012;27:589–93.
Schoen J, Meyerrose J, Paarmann H, Heringlake M, Hueppe M, Berger K-U. Preoperative regional cerebral oxygen saturation is a predictor of postoperative delirium in on-pump cardiac surgery patients: a prospective observational trial. Crit Care. 2011;15:R218.
Hatano Y, Narumoto J, Shibata K, Matsuoka T, Taniguchi S, Hata Y, Yamada K, Yaku H, Fukui K. White-matter hyperintensities predict delirium after cardiac surgery. Am J Geriatr Psychiatry. 2013;21:938–45.
Kazmierski J, Kowman M, Banach M, et al. Incidence and predictors of delirium after cardiac surgery: results from the IPDACS Study. J Psychosom Res. 2010;69:179–85.
Lin Y, Chen J, Wang Z. Meta-analysis of factors which influence delirium following cardiac surgery. J Card Surg. 2012;27:481–92.
Katznelson R, Djaiani GN, Borger MA, Friedman Z, Abbey SE, Fedorko L, Karski J, Mitsakakis N, Carroll J, Beattie WS. Preoperative use of statins is associated with reduced early delirium rates after cardiac surgery. Anesthesiology. 2009;110:67–73.
Rudolph JL, Jones RN, Levkoff SE, et al. Derivation and validation of a preoperative prediction rule for delirium after cardiac surgery. Circulation. 2009;119:229–36.
Ettema RGA, Van Koeven H, Peelen LM, Kalkman CJ, Schuurmans MJ. Preadmission interventions to prevent postoperative complications in older cardiac surgery patients: a systematic review. Int J Nurs Stud. 2014;51:251–60.
Arenson BG, MacDonald LA, Grocott HP, Hiebert BM, Arora RC. Effect of intensive care unit environment on in-hospital delirium after cardiac surgery. J Thorac Cardiovasc Surg. 2013;146:172–8.
Gamberini M, Bolliger D, Lurati Buse GA, et al. Rivastigmine for the prevention of postoperative delirium in elderly patients undergoing elective cardiac surgery--a randomized controlled trial. Crit Care Med. 2009;37:1762–8.
Hudetz JA, Patterson KM, Iqbal Z, Gandhi SD, Byrne AJ, Hudetz AG, Warltier DC, Pagel PS. Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 2009;23:651–7.
Shehabi Y, Grant P, Wolfenden H, Hammond N, Bass F, Campbell M, Chen J. Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study). Anesthesiology. 2009;111:1075–84.
Maldonado JR, Wysong A, van der Starre PJA, Block T, Miller C, Reitz BA. Dexmedetomidine and the reduction of postoperative delirium after cardiac surgery. Psychosomatics. 2009;50:206–17.
Mariscalco G, Cottini M, Zanobini M, et al. Preoperative statin therapy is not associated with a decrease in the incidence of delirium after cardiac operations. Ann Thorac Surg. 2012;93:1439–47.
Cole MG, Ciampi A, Belzile E, Dubuc-Sarrasin M. Subsyndromal delirium in older people: a systematic review of frequency, risk factors, course and outcomes. Int J Geriatr Psychiatry. 2013;28:771–80.
Hakim SM, Othman AI, Naoum DO. Early treatment with risperidone for subsyndromal delirium after on-pump cardiac surgery in the elderly: a randomized trial. Anesthesiol J Am Soc Anesthesiol. 2012;116:987–97.
Prakanrattana U, Prapaitrakool S. Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery. Anaesth Intensive Care. 2007;35:714–9.
Li H-C, Chen Y-S, Chiu M-J, Fu M-C, Huang G-H, Chen CC-H. Delirium, subsyndromal delirium, and cognitive changes in individuals undergoing elective coronary artery bypass graft surgery. J Cardiovasc Nurs. 2015;30:340–5.
Siepe M, Pfeiffer T, Gieringer A, Zemann S, Benk C, Schlensak C, Beyersdorf F. Increased systemic perfusion pressure during cardiopulmonary bypass is associated with less early postoperative cognitive dysfunction and delirium. Eur J Cardiothorac Surg. 2011;40:200–7.
Kazmierski J, Banys A, Latek J, Bourke J, Jaszewski R. Cortisol levels and neuropsychiatric diagnosis as markers of postoperative delirium: a prospective cohort study. Crit Care. 2013;17:R38.
Humphreys JM, Denson LA, Baker RA, Tully PJ. The importance of depression and alcohol use in coronary artery bypass graft surgery patients: risk factors for delirium and poorer quality of life. J Geriatr Cardiol. 2016;13:51–7.
Martin B-J, Buth KJ, Arora RC, Baskett RJ. Delirium as a predictor of sepsis in post-coronary artery bypass grafting patients: a retrospective cohort study. Crit Care. 2010;14:R171.
Aykut K, Albayrak G, Guzeloglu M, Baysak A, Hazan E. Preoperative mild cognitive dysfunction predicts pulmonary complications after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2013;27:1267–70.
Selnes OA, Goldsborough MA, Borowicz LM, McKhann GM. Neurobehavioural sequelae of cardiopulmonary bypass. Lancet. 1999;353:1601–6.
Moller J, Cluitmans P, Rasmussen L, et al. Long-term postoperative cognitive dysfunction in the elderly: ISPOCD1 Study. Lancet. 1998;351:857–61.
Evered LA, Silbert BS, Scott DA, Maruff P, Ames D. Prevalence of dementia 7.5 years after coronary artery bypass graft surgery. Anesthesiology. 2016;125:62–71.
Newman MF, Kirchner JL, Phillips-Bute B, Gaver V, Grocott H, Jones RH, Mark DB, Reves JG, Blumenthal JA. Longitudinal assessment of neurocognitive function after coronary-artery bypass surgery. N Engl J Med. 2001;344:395–402.
Selnes OA, Royall RM, Grega MA, Louis M, Borowicz J, Quaskey S, McKhann GM. Cognitive changes 5 years after coronary artery bypass grafting: is there evidence of late decline? Arch Neurol. 2001;58:598–604.
Gottesman RF, Wityk RJ. Brain injury from cardiac bypass procedures. Semin Neurol. 2006;26:432–9.
Tully PJ, Baker RA, Kneebone AC, Knight JL. Neuropsychologic and quality-of-life outcomes after coronary artery bypass surgery with and without cardiopulmonary bypass: a prospective randomized trial. J Cardiothorac Vasc Anesth. 2008;22:515–21.
van Dijk D, Spoor M, Hijman R, Nathoe HM, Borst C, Jansen EWL, Grobbee DE, de Jaegere PPT, Kalkman CJ, Group for the OS. Cognitive and cardiac outcomes 5 years after off-pump vs on-pump coronary artery bypass graft surgery. JAMA. 2007;297:701–8.
Kennedy ED, Choy KCC, Alston RP, Chen S, Farhan-Alanie MMH, Anderson J, Ang YL, Moore DE, MacKenzie SA, Sykes RA. Cognitive outcome after on- and off-pump coronary artery bypass grafting surgery: a systematic review and meta-analysis. J Cardiothorac Vasc Anesth. 2013;27:253–65.
van Dijk D, Moons KGM, Nathoe HM, van Aarnhem EHL, Borst C, Keizer AMA, Kalkman CJ, Hijman R. Cognitive outcomes five years after not undergoing coronary artery bypass graft surgery. Ann Thorac Surg. 2008;85:60–4.
Cormack F, Shipolini A, Awad WI, Richardson C, McCormack DJ, Colleoni L, Underwood M, Baldeweg T, Hogan AM. A meta-analysis of cognitive outcome following coronary artery bypass graft surgery. Neurosci Biobehav Rev. 2012;36:2118–29.
Selnes OA, Gottesman RF, Grega MA, Baumgartner WA, Zeger SL, McKhann GM. Cognitive and neurologic outcomes after coronary-artery bypass surgery. 2012. In: https://doi.org/10.1056/NEJMra1100109. http://www.nejm.org/doi/full/10.1056/NEJMra1100109. Accessed 14 May 2017.
Celano CM, Huffman JC. Depression and cardiac disease: a review. Cardiol Rev. 2011;19:130–42.
Johansson P, Dahlström U, Alehagen U. Depressive symptoms and six-year cardiovascular mortality in elderly patients with and without heart failure. Scand Cardiovasc J. 2007;41:299–307.
Whooley MA, de JP, Vittinghoff E, et al. Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA. 2008;300:2379–88.
Horne D, Kehler DS, Kaoukis G, Hiebert B, Garcia E, Chapman S, Duhamel TA, Arora RC. Impact of physical activity on depression after cardiac surgery. Can J Cardiol. 2013;29:1649–56.
Martin F. Recognizing depression after a coronary artery bypass graft. Br J Nurs. 2006;15:703–6.
Barth J, Schumacher M, Herrmann-Lingen C. Depression as a risk factor for mortality in patients with coronary heart disease: a meta-analysis. Psychosom Med. 2004;66:802–13.
Feinstein RE, Blumenfield M, Orlowski B, Frishman WH, Ovanessian S. A national survey of cardiovascular physicians’ beliefs and clinical care practices when diagnosing and treating depression in patients with cardiovascular disease. Cardiol Rev. 2006;14:164–9.
Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA. 2003;289:3095–105.
Connerney I, Shapiro PA, McLaughlin JS, Bagiella E, Sloan RP. Relation between depression after coronary artery bypass surgery and 12-month outcome: a prospective study. Lancet. 2001;358:1766–71.
Tully PJ, Baker RA, Winefield HR, Turnbull DA. Depression, anxiety disorders and type D personality as risk factors for delirium after cardiac surgery. Aust N Z J Psychiatry. 2010;44:1005–11.
Mitchell RHB, Robertson E, Harvey PJ, Nolan R, Rodin G, Romans S, Abramson BL, Brister SJ, Ivanov J, Stewart DE. Sex differences in depression after coronary artery bypass graft surgery. Am Heart J. 2005;150:1017–25.
Blumenthal JA, Lett HS, Babyak MA, White W, Smith PK, Mark DB, Jones R, Mathew JP, Newman MF, NORG Investigators. Depression as a risk factor for mortality after coronary artery bypass surgery. Lancet. 2003;362:604–9.
Baker RA, Andrew MJ, Schrader G, Knight JL. Preoperative depression and mortality in coronary artery bypass surgery: preliminary findings. ANZ J Surg. 2001;71:139–42.
Gallagher R, McKinley S. Anxiety, depression and perceived control in patients having coronary artery bypass grafts. J Adv Nurs. 2009;65:2386–96.
Borowicz L, Royall R, Grega M, Selnes O, Lyketsos C, McKhann G. Depression and cardiac morbidity 5 years after coronary artery bypass surgery. Psychosomatics. 2002;43:464–71.
McKhann GM, Borowicz LM, Goldsborough MA, Enger C, Selnes OA. Depression and cognitive decline after coronary artery bypass grafting. Lancet. 1997;349:1282–4.
Pirraglia PA, Peterson JC, Williams-Russo P, Gorkin L, Charlson ME. Depressive symptomatology in coronary artery bypass graft surgery patients. Int J Geriatr Psychiatry. 1999;14:668–80.
Krannich J-HA, Weyers P, Lueger S, Herzog M, Bohrer T, Elert O. Presence of depression and anxiety before and after coronary artery bypass graft surgery and their relationship to age. BMC Psychiatry. 2007;7:47.
Timberlake N, Klinger L, Smith P, Venn G, Treasure T, Harrison M, Newman SP. Incidence and patterns of depression following coronary artery bypass graft surgery. J Psychosom Res. 1997;43:197–207.
Phillips-Bute B, Mathew JP, Blumenthal JA, et al. Relationship of genetic variability and depressive symptoms to adverse events after coronary artery bypass graft surgery. Psychosom Med. 2008;70:953–9.
Lie I, Arnesen H, Sandvik L, Hamilton G, Bunch EH. Effects of a home-based intervention program on anxiety and depression 6 months after coronary artery bypass grafting: a randomized controlled trial. J Psychosom Res. 2007;62:411–8.
Beresnevaitė M, Benetis R, Taylor GJ, Jurėnienė K, Kinduris Š, Barauskienė V. Depression predicts perioperative outcomes following coronary artery bypass graft surgery. Scand Cardiovasc J. 2010;44:289–94.
Burg MM, Benedetto MC, Rosenberg R, Soufer R. Presurgical depression predicts medical morbidity 6 months after coronary artery bypass graft surgery. Psychosom Med. 2003;65:111–8.
Tully PJ, Baker RA, Turnbull D, Winefield H. The role of depression and anxiety symptoms in hospital readmissions after cardiac surgery. J Behav Med. 2008;31:281–90.
Mallik S, Krumholz HM, Lin ZQ, Kasl SV, Mattera JA, Roumains SA, Vaccarino V. Patients with depressive symptoms have lower health status benefits after coronary artery bypass surgery. Circulation. 2005;111:271–7.
Stenman M, Holzmann MJ, Sartipy U. Relation of major depression to survival after coronary artery bypass grafting. Am J Cardiol. 2014;114:698–703.
Stenman M, Holzmann MJ, Sartipy U. Association between preoperative depression and long-term survival following coronary artery bypass surgery — a systematic review and meta-analysis. Int J Cardiol. 2016;222:462–6.
Dao TK, Chu D, Springer J, Gopaldas RR, Menefee DS, Anderson T, Hiatt E, Nguyen Q. Clinical depression, posttraumatic stress disorder, and comorbid depression and posttraumatic stress disorder as risk factors for in-hospital mortality after coronary artery bypass grafting surgery. J Thorac Cardiovasc Surg. 2010;140:606–10.
Burg MM, Benedetto MC, Soufer R. Depressive symptoms and mortality two years after coronary artery bypass graft surgery (CABG) in men. Psychosom Med. 2003;65:508–10.
Connerney I, Sloan RP, Shapiro PA, Bagiella E, Seckman C. Depression is associated with increased mortality 10 years after coronary artery bypass surgery. Psychosom Med. 2010;72:874–81.
Nemati MH, Astaneh B. The impact of coronary artery bypass graft surgery on depression and anxiety. J Cardiovasc Med (Hagerstown). 2011;12:401–4.
Kustrzycki W, Rymaszewska J, Malcher K, Szczepanska-Gieracha J, Biecek P. Risk factors of depressive and anxiety symptoms 8 years after coronary artery bypass grafting. Eur J Cardiothorac Surg. 2012;41:302–6.
Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with coronary artery disease. Cochrane Database Syst Rev. 2011. https://doi.org/10.1002/14651858.CD008012.pub3.
Glassman AH, O’Connor CM, Califf RM, et al. Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA. 2002;288:701–9.
Lespérance F, Frasure-Smith N, Koszycki D, et al. Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: the Canadian Cardiac Randomized Evaluation of Antidepressant and Psychotherapy Efficacy (CREATE) trial. JAMA. 2007;297:367–79.
Kim DH, Daskalakis C, Whellan DJ, Whitman IR, Hohmann S, Medvedev S, Kraft WK. Safety of selective serotonin reuptake inhibitor in adults undergoing coronary artery bypass grafting. Am J Cardiol. 2009;103:1391–5.
Tully PJ, Cardinal T, Bennetts JS, Baker RA. Selective serotonin reuptake inhibitors, venlafaxine and duloxetine are associated with in hospital morbidity but not bleeding or late mortality after coronary artery bypass graft surgery. Heart Lung Circ. 2012;21:206–14.
Chocron S, Vandel P, Durst C, Laluc F, Kaili D, Chocron M, Etievent J-P. Antidepressant therapy in patients undergoing coronary artery bypass grafting: the MOTIV-CABG trial. Ann Thorac Surg. 2013;95:1609–18.
Targownik LE, Bolton JM, Metge CJ, Leung S, Sareen J. Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding. Am J Gastroenterol. 2009;104:1475.
Xiong GL, Jiang W, Clare R, Shaw LK, Smith PK, Mahaffey KW, O’Connor CM, Krishnan KRR, Newby LK. Prognosis of patients taking selective serotonin reuptake inhibitors before coronary artery bypass grafting. Am J Cardiol. 2006;98:42–7.
Stenman M, Holzmann MJ, Sartipy U. Antidepressant use before coronary artery bypass surgery is associated with long-term mortality. Int J Cardiol. 2013;167:2958–62.
Freedland KE, Skala JA, Carney RM, Rubin EH, Lustman PJ, Dávila-Román VG, Steinmeyer BC, Hogue CW. Treatment of depression after coronary artery bypass surgery: a randomized controlled trial. Arch Gen Psychiatry. 2009;66:387–96.
Dickens C, Cherrington A, Adeyemi I, Roughley K, Bower P, Garrett C, Bundy C, Coventry P. Characteristics of psychological interventions that improve depression in people with coronary heart disease: a systematic review and meta-regression. Psychosom Med. 2013;75:211–21.
Hwang B, Eastwood J-A, McGuire A, Chen B, Cross-Bodán R, Doering LV. Cognitive behavioral therapy in depressed cardiac surgery patients: role of ejection fraction. J Cardiovasc Nurs. 2015;30:319–24.
Donohue JM, Belnap BH, Men A, He F, Roberts MS, Schulberg HC, Reynolds CF, Rollman BL. Twelve-month cost-effectiveness of telephone-delivered collaborative care for treating depression following CABG surgery: a randomized controlled trial. Gen Hosp Psychiatry. 2014;36:453–9.
Morone NE, Weiner DK, Belnap BH, Hum B, Karp JF, Mazumdar S, Houck PR, He F, Rollman BL. The impact of pain and depression on post-CABG recovery. Psychosom Med. 2010;72:620–5.
Rollman BL, Belnap BH. The bypassing the blues trial: collaborative care for post-CABG depression and implications for future research. Cleve Clin J Med. 2011;78(Suppl 1):S4–12.
Shuldham CM, Fleming S, Goodman H. The impact of pre-operative education on recovery following coronary artery bypass surgery. A randomized controlled clinical trial. Eur Heart J. 2002;23:666–74.
Wood WG, Eckert GP, Igbavboa U, Müller WE. Statins and neuroprotection: a prescription to move the field forward. Ann N Y Acad Sci. 2010;1199:69–76.
Mulhaupt F, Matter CM, Kwak BR, Pelli G, Veillard NR, Burger F, Graber P, Lüscher TF, Mach F. Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in human vascular cells. Cardiovasc Res. 2003;59:755–66.
Vuletic S, Riekse RG, Marcovina SM, Peskind ER, Hazzard WR, Albers JJ. Statins of different brain penetrability differentially affect CSF PLTP activity. Dement Geriatr Cogn Disord. 2006;22:392–8.
Abbasi SH, Mohammadinejad P, Shahmansouri N, Salehiomran A, Beglar AA, Zeinoddini A, Forghani S, Akhondzadeh S. Simvastatin versus atorvastatin for improving mild to moderate depression in post-coronary artery bypass graft patients: a double-blind, placebo-controlled, randomized trial. J Affect Disord. 2015;183:149–55.
Hoyer J, Eifert GH, Einsle F, Zimmermann K, Krauss S, Knaut M, Matschke K, Köllner V. Heart-focused anxiety before and after cardiac surgery. J Psychosom Res. 2008;64:291–7.
Koivula M, Tarkka M-T, Tarkka M, Laippala P, Paunonen-Ilmonen M. Fear and anxiety in patients at different time-points in the coronary artery bypass process. Int J Nurs Stud. 2002;39:811–22.
Fitzsimons D, Parahoo K, Richardson SG, Stringer M. Patient anxiety while on a waiting list for coronary artery bypass surgery: a qualitative and quantitative analysis. Heart Lung. 2003;32:23–31.
Székely A, Balog P, Benkö E, Breuer T, Székely J, Kertai MD, Horkay F, Kopp MS, Thayer JF. Anxiety predicts mortality and morbidity after coronary artery and valve surgery--a 4-year follow-up study. Psychosom Med. 2007;69:625–31.
Tully PJ, Baker RA, Knight JL. Anxiety and depression as risk factors for mortality after coronary artery bypass surgery. J Psychosom Res. 2008;64:285–90.
Tully PJ, Winefield HR, Baker RA, Denollet J, Pedersen SS, Wittert GA, Turnbull DA. Depression, anxiety and major adverse cardiovascular and cerebrovascular events in patients following coronary artery bypass graft surgery: a five year longitudinal cohort study. Biopsychosoc Med. 2015;9:14.
Tully PJ, Bennetts JS, Baker RA, McGavigan AD, Turnbull DA, Winefield HR. Anxiety, depression, and stress as risk factors for atrial fibrillation after cardiac surgery. Heart Lung. 2011;40:4–11.
Burkauskas J, Brozaitiene J, Bunevicius A, Neverauskas J, Zaliunaite V, Bunevicius R. Association of depression, anxiety, and type D personality with cognitive function in patients with coronary artery disease. Cogn Behav Neurol. 2016;29:91–9.
Hudetz JA, Gandhi SD, Iqbal Z, Patterson KM, Byrne AJ, Warltier DC, Pagel PS. History of post-traumatic stress disorder is associated with impaired neuropsychometric performance after coronary artery surgery. J Cardiothorac Vasc Anesth. 2010;24:964–8.
Schelling G, Richter M, Roozendaal B, Rothenhäusler H-B, Krauseneck T, Stoll C, Nollert G, Schmidt M, Kapfhammer H-P. Exposure to high stress in the intensive care unit may have negative effects on health-related quality-of-life outcomes after cardiac surgery. Crit Care Med. 2003;31:1971–80.
Stoll C, Schelling G, Goetz AE, Kilger E, Bayer A, Kapfhammer H-P, Rothenhäusler H-B, Kreuzer E, Reichart B, Peter K. Health-related quality of life and post-traumatic stress disorder in patients after cardiac surgery and intensive care treatment. J Thorac Cardiovasc Surg. 2000;120:505–12.
Tarsitani L, De Santis V, Mistretta M, Parmigiani G, Zampetti G, Roselli V, Vitale D, Tritapepe L, Biondi M, Picardi A. Treatment with β-blockers and incidence of post-traumatic stress disorder after cardiac surgery: a prospective observational study. J Cardiothorac Vasc Anesth. 2012;26:265–9.
Grabas MP, Hansen SM, Torp-Pedersen C, Bøggild H, Ullits LR, Deding U, Nielsen BJ, Jensen PF, Overgaard C. Alcohol consumption and mortality in patients undergoing coronary artery bypass graft (CABG)-a register-based cohort study., alcohol consumption and mortality in patients undergoing coronary artery bypass graft (CABG)-a register-based cohort study. BMC Cardiovasc Disord. 2016;16(16):219.
Maheshwari A, Dalton JE, Yared J-P, Mascha EJ, Kurz A, Sessler DI. The association between alcohol consumption and morbidity and mortality in patients undergoing coronary artery bypass surgery. J Cardiothorac Vasc Anesth. 2010;24:580–5.
Mukamal KJ, Girotra S, Mittleman MA. Alcohol consumption, atherosclerotic progression, and prognosis among patients with coronary artery bypass grafts. Am Heart J. 2006;151:368–72.
Lindsay GM, Tolmie EP, Martin WM, Hutton IM, Belcher PR. Smoking after coronary artery bypass: high three-year mortality. Thorac Cardiovasc Surg. 2009;57:135–40.
Nkomo VT, Gardin JM, Skelton TN, Gottdiener JS, Scott CG, Enriquez-Sarano M. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005–11.
Hudetz JA, Iqbal Z, Gandhi SD, Patterson KM, Byrne AJ, Pagel PS. Postoperative delirium and short-term cognitive dysfunction occur more frequently in patients undergoing valve surgery with or without coronary artery bypass graft surgery compared with coronary artery bypass graft surgery alone: results of a pilot study. J Cardiothorac Vasc Anesth. 2011;25:811–6.
Maniar HS, Lindman BR, Escallier K, et al. Delirium after surgical and transcatheter aortic valve replacement is associated with increased mortality. J Thorac Cardiovasc Surg. 2016;151:815–23. e2
Ebert AD, Walzer TA, Huth C, Herrmann M. Early neurobehavioral disorders after cardiac surgery: a comparative analysis of coronary artery bypass graft surgery and valve replacement. J Cardiothorac Vasc Anesth. 2001;15:15–9.
Vingerhoets G, Van Nooten G, Vermassen F, De Soete G, Jannes C. Short-term and long-term neuropsychological consequences of cardiac surgery with extracorporeal circulation. Eur J Cardiothorac Surg. 1997;11:424–31.
Knipp SC, Weimar C, Schlamann M, Schweter S, Wendt D, Thielmann M, Benedik J, Jakob H. Early and long-term cognitive outcome after conventional cardiac valve surgery. Interact Cardiovasc Thorac Surg. 2017;24:534–40.
Stortecky S, Schmid V, Windecker S, Kadner A, Pilgrim T, Buellesfeld L, Khattab AA, Wenaweser P. Improvement of physical and mental health after transfemoral transcatheter aortic valve implantation. EuroIntervention J Eur Collab Work Group Interv Cardiol Eur Soc Cardiol. 2012;8:437–43.
Oterhals K, Hanssen TA, Haaverstad R, Nordrehaug JE, Eide GE, Norekvål TM. Factors associated with poor self-reported health status after aortic valve replacement with or without concomitant bypass surgery. Eur J Cardiothorac Surg. 2015;48:283–92.
Jamieson WR, Edwards FH, Schwartz M, Bero JW, Clark RE, Grover FL. Risk stratification for cardiac valve replacement. National Cardiac Surgery Database. Database Committee of the Society of Thoracic Surgeons. Ann Thorac Surg. 1999;67:943–51.
Ho PM, Masoudi FA, Spertus JA, Peterson PN, Shroyer AL, McCarthy M Jr, Grover FL, Hammermeister KE, Rumsfeld JS. Depression predicts mortality following cardiac valve surgery. Ann Thorac Surg. 2005;79:1255–9.
Abawi M, Nijhoff F, Agostoni P, Emmelot-Vonk MH, de Vries R, Doevendans PA, Stella PR. Incidence, predictive factors, and effect of delirium after Transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2016;9:160–8.
Holmes DR, Nishimura RA, Grover FL, et al. Annual outcomes with Transcatheter valve therapy. J Am Coll Cardiol. 2015;66:2813–23.
Eide LSP, Ranhoff AH, Fridlund B, Haaverstad R, Hufthammer KO, Kuiper KKJ, Nordrehaug JE, Norekvål TM. Comparison of frequency, risk factors, and time course of postoperative delirium in octogenarians after Transcatheter aortic valve implantation versus surgical aortic valve replacement. Am J Cardiol. 2015;115:802–9.
Eide LSP, Ranhoff AH, Fridlund B, Haaverstad R, Hufthammer KO, Kuiper KKJ, Nordrehaug JE, Norekvål TM. Readmissions and mortality in delirious versus non-delirious octogenarian patients after aortic valve therapy: a prospective cohort study. BMJ Open. 2016;6:e012683.
Carozza A, De Santo LS, Romano G, Della Corte A, Ursomando F, Scardone M, Caianiello G, Cotrufo M. Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment. J Heart Valve Dis. 2006;15:125–31.
Kaiser SP, Melby SJ, Zierer A, Schuessler RB, Moon MR, Moazami N, Pasque MK, Huddleston C, Damiano RJ Jr, Lawton JS. Long-term outcomes in valve replacement surgery for infective endocarditis. Ann Thorac Surg. 2007;83:30–5.
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation. 2015;132:1435–86.
Hartman L, Barnes E, Bachmann L, Schafer K, Lovato J, Files DC. Opiate injection-associated infective endocarditis in the Southeastern United States. Am J Med Sci. 2016;352:603–8.
Miró JM, del RÃo A, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin. 2003;21:167–84. v–vi.
Yuan S-M. Right-sided infective endocarditis: recent epidemiologic changes. Int J Clin Exp Med. 2014;7:199–218.
Østerdal OB, Salminen P-R, Jordal S, Sjursen H, Wendelbo Ø, Haaverstad R. Cardiac surgery for infective endocarditis in patients with intravenous drug use. Interact Cardiovasc Thorac Surg. 2016;22:633–40.
Lemaire A, Dombrovskiy V, Saadat S, Batsides G, Ghaly A, Spotnitz A, Lee LY. Patients with infectious endocarditis and drug dependence have worse clinical outcomes after valvular surgery. Surg Infect. 2017;18:299–302.
Wahba A, Nordhaug D. What are the long-term results of cardiac valve replacements in left sided endocarditis with a history of i.v. drug abuse? Interact Cardiovasc Thorac Surg. 2006;5:608–10.
Connery HS. Medication-assisted treatment of opioid use disorder: review of the evidence and future directions. Harv Rev Psychiatry. 2015;23:63–75.
Suzuki J. Medication-assisted treatment for hospitalized patients with intravenous-drug-use related infective endocarditis. Am J Addict. 2016;25:191–4.
Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, Miller MA, Baldwin JT, Young JB. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015;34:1495–504.
Feldman D, Pamboukian SV, Teuteberg JJ, et al. The 2013 International Society for Heart and Lung Transplantation guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant. 2013;32:157–87.
Wilson SR, Mudge GH, Stewart GC, Givertz MM. Evaluation for a ventricular assist device selecting the appropriate candidate. Circulation. 2009;119:2225–32.
Rustad JK, Stern TA, Hebert KA, Musselman DL. Diagnosis and treatment of depression in patients with congestive heart failure: a review of the literature. Prim Care Companion CNS Disord. 2013. https://doi.org/10.4088/PCC.13r01511.
Friedmann E, Thomas SA, Liu F, Morton PG, Chapa D, Gottlieb SS. Relationship of depression, anxiety, and social isolation to chronic heart failure outpatient mortality. Am Heart J. 2006;152:940.e1–8.
Haworth JE, Moniz-Cook E, Clark AL, Wang M, Waddington R, Cleland JGF. Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction. Eur J Heart Fail. 2005;7:803–8.
Eriksson M, Samuelsson E, Gustafson Y, Aberg T, Engström KG. Delirium after coronary bypass surgery evaluated by the organic brain syndrome protocol. Scand Cardiovasc J. 2002;36:250–5.
Higashi H, Inaba S, Saito M, Yamaoka M, Yanagimoto R, Okiura N, Gen Y, Kojima Y, Sumimoto T. Heart failure as a strong independent predictor of delirium after pacemaker operations. IJC Metab Endocr. 2015;8:42–5.
Petrucci R, Kushon D, Inkles R, Fitzpatrick J, Twomey C, Samuels L. Cardiac ventricular support: considerations for psychiatry. Psychosomatics. 1999;40:298–303.
Baba A, Hirata G, Yokoyama F, Kenmoku K, Tsuchiya M, Kyo S, Toyoshima R. Psychiatric problems of heart transplant candidates with left ventricular assist devices. J Artif Organs. 2006;9:203–8.
Shapiro PA, Levin HR, Oz MC. Left ventricular assist devices psychosocial burden and implications for heart transplant programs. Gen Hosp Psychiatry. 1996;18(6 Suppl):30–5.
Rose EA, Gelijns AC, Moskowitz AJ, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–43.
Reynard AK, Butler RS, McKee MG, Starling RC, Gorodeski EZ. Frequency of depression and anxiety before and after insertion of a continuous flow left ventricular assist device. Am J Cardiol. 2014;114:433–40.
Yost G, Bhat G, Mahoney E, Tatooles A. Reduced anxiety and depression in patients with advanced heart failure after left ventricular assist device implantation. Psychosomatics. 2017;58:406–14.
Caro MA, Patare A, Oldham M, Bellumkonda L, Chen M, Bonde P, Lee HB. Conference paper. Prevalence of Pre-surgical Neuropsychiatric Disorders and Cognitive Impairment among Left-ventricular Assist DEvice (LVAD) Recipients. Presented at the 2017 Academy of Psychosomatic Medicine Annual Meeting; 2017.
The Data Collection and Analysis Center. University of Alabama at Birmingham Intermacs Appendix A- Adverse Event Definitions.
Yuan N, Arnaoutakis GJ, George TJ, Allen JG, Ju DG, Schaffer JM, Russell SD, Shah AS, Conte JV. The spectrum of complications following left ventricular assist device placement. J Card Surg. 2012;27:630–8.
Dew MA, Kormos RL, Winowich S, Harris RC, Stanford EA, Carozza L, Griffith BP. Quality of life outcomes after heart transplantation in individuals bridged to transplant with ventricular assist devices. J Heart Lung Transplant. 2001;20:1199–212.
Brouwers C, Denollet J, Caliskan K, de Jonge N, Constantinescu A, Young Q, Kaan A, Pedersen SS. Psychological distress in patients with a left ventricular assist device and their partners: an exploratory study. Eur J Cardiovasc Nurs. 2013;14(1):53–62. https://doi.org/10.1177/1474515113517607.
Bunzel B, Laederach-Hofmann K, Wieselthaler G, Roethy W, Wolner E. Mechanical circulatory support as a bridge to heart transplantation: what remains? Long-term emotional Sequelae in patients and spouses. J Heart Lung Transplant. 2007;26:384–9.
Bunzel B, Laederach-Hofmann K, Wieselthaler GM, Roethy W, Drees G. Posttraumatic stress disorder after implantation of a mechanical assist device followed by heart transplantation: evaluation of patients and partners. Transplant Proc. 2005;37:1365–8.
Hajduk AM, Kiefe CI, Person SD, Gore JG, Saczynski JS. Cognitive change in heart failure a systematic review. Circ Cardiovasc Qual Outcomes. 2013;6:451–60.
Pressler SJ, Subramanian U, Kareken D, et al. Cognitive deficits in chronic heart failure. Nurs Res. 2010;59:127–39.
Bhat G, Yost G, Mahoney E. Cognitive function and left ventricular assist device implantation. J Heart Lung Transplant. 2015;34:1398–405.
Tigges-Limmer K, Schönbrodt M, Roefe D, Arusoglu L, Morshuis M, Gummert JF. Suicide after ventricular assist device implantation. J Heart Lung Transplant. 2010;29:692–4.
Augustin M, Bruells CS, Moza A, Gillmann B, Mevissen L, Grözinger M. Electroconvulsive therapy in a patient with left ventricular assist device following deliberate disconnection of the device driveline. Brain Stimul. 2017;10:843–4.
Bond AE, Bolton B, Nelson K. Nursing education and implications for left ventricular assist device destination therapy. Prog Cardiovasc Nurs. 2004;19:85–91.
Stahl MAM, Richards NM. Ventricular assist devices: developing and maintaining a training and competency program. J Cardiovasc Nurs. 2002;16:34–43.
Connors JM. Anticoagulation management of left ventricular assist devices. Am J Hematol. 2014;90:175–8.
Anglin R, Yuan Y, Moayyedi P, Tse F, Armstrong D, Leontiadis GI. Risk of upper gastrointestinal bleeding with selective serotonin reuptake inhibitors with or without concurrent nonsteroidal anti-inflammatory use: a systematic review and meta-analysis. Am J Gastroenterol. 2014;109:811–9.
Crow S, Chen D, Milano C, et al. Acquired von Willebrand syndrome in continuous-flow ventricular assist device recipients. Ann Thorac Surg. 2010;90:1263–9.
Meyer AL, Malehsa D, Budde U, Bara C, Haverich A, Strueber M. Acquired von Willebrand syndrome in patients with a centrifugal or axial continuous flow left ventricular assist device. JACC Heart Fail. 2014;2:141–5.
de Abajo FJ, GarcÃa-RodrÃguez LA. Risk of upper gastrointestinal tract bleeding associated with selective serotonin reuptake inhibitors and venlafaxine therapy: interaction with nonsteroidal anti-inflammatory drugs and effect of acid-suppressing agents. Arch Gen Psychiatry. 2008;65:795–803.
Halperin D, Reber G. Influence of antidepressants on hemostasis. Dialogues Clin Neurosci. 2007;9:47–59.
Labos C, Dasgupta K, Nedjar H, Turecki G, Rahme E. Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction. CMAJ. 2011;183:1835–43.
Harding JD, Piacentino IIIV, Rothman S, Chambers S, Jessup M, Margulies KB. Prolonged repolarization after ventricular assist device support is associated with arrhythmias in humans with congestive heart failure. J Card Fail. 2005;11:227–32.
Harding JD, Piacentino V, Gaughan JP, Houser SR, Margulies KB. Electrophysiological alterations after mechanical circulatory support in patients with advanced cardiac failure. Circulation. 2001;104:1241–7.
Genovese EA, Dew MA, Teuteberg JJ, et al. Incidence and patterns of adverse event onset during the first 60 days after ventricular assist device implantation. Ann Thorac Surg. 2009;88:1162–70.
Beach SR, Celano CM, Noseworthy PA, Januzzi JL, Huffman JC. QTc prolongation, Torsades de pointes, and psychotropic medications. Psychosomatics. 2013;54:1–13.
Baghai TC, Möller H-J. Electroconvulsive therapy and its different indications. Dialogues Clin Neurosci. 2008;10:105–17.
Bruce CR. A review of ethical considerations for ventricular assist device placement in older adults. Aging Dis. 2013;4:100–12.
Petrucci RJ, Benish LA, Carrow BL, Prato L, Hankins SR, Eisen HJ, Entwistle JW. Ethical considerations for ventricular assist device support: a 10-point model. ASAIO J. 2011;57:268–73.
Freedenberg V, Thomas SA, Friedmann E. Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review. Heart Fail Clin. 2011;7:59–68.
Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877–83.
Bardy GH, Lee KL, Mark DB, et al. Amiodarone or an implantable cardioverter–defibrillator for congestive heart failure. N Engl J Med. 2005;352:225–37.
Bostwick JM, Sola CL. An updated review of implantable cardioverter/defibrillators, induced anxiety, and quality of life. Psychiatr Clin North Am. 2007;30:677–88.
Sears SF, Conti JB. Understanding implantable cardioverter defibrillator shocks and storms: medical and psychosocial considerations for research and clinical care. Clin Cardiol. 2003;26:107–11.
Camm AJ, Sears SF, Todaro JF, Lewis TS, Sotile W, Conti JB. Examining the psychosocial impact of implantable cardioverter defibrillators: a literature review. Clin Cardiol. 1999;22:481–9.
Kapa S, Rotondi-Trevisan D, Mariano Z, Aves T, Irvine J, Dorian P, Hayes DL. Psychopathology in patients with ICDs over time: results of a prospective study. Pacing Clin Electrophysiol. 2010;33:198–208.
Manzoni GM, Castelnuovo G, Compare A, Pagnini F, Essebag V, Proietti R. Psychological effects of implantable cardioverter defibrillator shocks. A review of study methods. Front Psychol. 2015;6:39.
Pedersen SS, Theuns DAMJ, Jordaens L, Kupper N. Course of anxiety and device-related concerns in implantable cardioverter defibrillator patients the first year post implantation. Europace. 2010;12:1119–26.
Thylén I, Dekker RL, Jaarsma T, Strömberg A, Moser DK. Characteristics associated with anxiety, depressive symptoms, and quality-of-life in a large cohort of implantable cardioverter defibrillator recipients. J Psychosom Res. 2014;77:122–7.
Habibović M, Burg MM, Pedersen SS. Behavioral interventions in patients with an implantable cardioverter defibrillator: lessons learned and where to go from here? Pacing Clin Electrophysiol. 2013;36:578–90.
Brojmohun A, Lou JY, Zardkoohi O, Funk MC. Protected from torsades de pointes? What psychiatrists need to know about pacemakers and defibrillators. Psychosomatics. 2013;54:407–17.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Piddoubny, W., Caro, M.A. (2019). Psychiatric Aspects of Cardiothoracic Surgery. In: Zimbrean, P., Oldham, M., Lee, H. (eds) Perioperative Psychiatry. Springer, Cham. https://doi.org/10.1007/978-3-319-99774-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-319-99774-2_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-99773-5
Online ISBN: 978-3-319-99774-2
eBook Packages: MedicineMedicine (R0)